Askowitz Gerald N Dr Optmtrst Res is categorized under Physicians Offices in Miami, FL and active since 2010.
Askowitz Gerald N Dr Optmtrst Res was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Gerald N Askowitz at the company’s single location by writing to 12101 Sw 93rd Avenue, Miami, Florida FL 33176 or by phoning (305) 253-6994. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Askowitz Gerald N Dr Optmtrst Res |
| Contact Person: | Gerald N Askowitz |
| Address: | 12101 Sw 93rd Avenue, Miami, Florida 33176 |
| Phone Number: | (305) 253-6994 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Askowitz Gerald N Dr Optmtrst Res was started in 2010 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gerald N Askowitz for inquiries that concern Askowitz Gerald N Dr Optmtrst Res by calling the company number (305) 253-6994, as your correspondence is most welcome. Additionally, the physical location of the single location of Askowitz Gerald N Dr Optmtrst Res can be found at the coordinates 25.657483,-80.344603 as well as the street address 12101 Sw 93rd Avenue in Miami, Florida 33176.
For its online presence, you may visit Askowitz Gerald N Dr Optmtrst Res’s website at and engage with its social media outlets through on Twitter and on Facebook.